Discovery and preclinical evaluation of a novel highly selective and potent CDK12 inhibitor

被引：0
|
作者：
Yamakawa, Hiroko [1 ]
Mizutani, Akio [1 ]
Arikawa, Yasuyoshi [1 ]
Ebara, Shunsuke [1 ]
Satoh, Yoshihiko [1 ]
Morishita, Daisuke [1 ]
机构：
[1] Chordia Therapeut Inc, Fujisawa, Kanagawa, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5485
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
    Gu, WZ
    Joseph, I
    Wang, YC
    Frost, D
    Sullivan, GM
    Wang, L
    Lin, NH
    Cohen, J
    Stoll, VS
    Jakob, CG
    Muchmore, SW
    Harlan, JE
    Holzman, T
    Walten, KA
    Ladror, US
    Anderson, MG
    Kroeger, P
    Rodriguez, LE
    Jarvis, KP
    Ferguson, D
    Marsh, K
    Ng, SC
    Rosenberg, SH
    Sham, HL
    Zhang, HY
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1059 - 1069
  • [42] Potent anti-tumor activity correlated with inhibition of DNA damage response genes with highly selective and orally bioavailable CDK12 covalent inhibitors
    Poddutoori, R.
    Rajagopalan, S.
    Mukherjee, S.
    Marappan, S.
    Samiulla, D.
    Nayak, S.
    Sivakumar, S.
    Ravindra, M.
    Gore, S.
    Dhudashiya, A.
    Charamanna, K.
    Daginakatte, G.
    Chelur, S.
    Ramachandra, M.
    Samajdar, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E94 - E95
  • [43] Discovery of a novel olefin derivative as a highly potent and selective acetyl-CoA carboxylase 2 inhibitor
    Nishiura, Yuji
    Matsumura, Akira
    Kobayashi, Naotake
    Shimazaki, Atsuyuki
    Sakamoto, Shingo
    Kitade, Naohisa
    Tonomura, Yutaka
    Ino, Akira
    Okuno, Takayuki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [44] Preclinical in vivo characterization of INCB028060, a novel, potent and highly selective c-Met inhibitor
    Koblish, H. K.
    Liu, X.
    Hall, L.
    Boer, J.
    He, C.
    Yeleswaram, S.
    Newton, R. C.
    Vaddi, K.
    Yao, W.
    Scherle, P. A.
    Fridman, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Structure-Based Design of Selective Noncovalent CDK12 Inhibitors
    Johannes, Jeffrey W.
    Denz, Christopher R.
    Su, Nancy
    Wu, Allan
    Impastato, Anna C.
    Mlynarski, Scott
    Varnes, Jeffrey G.
    Prince, D. Bryan
    Cidado, Justin
    Gao, Ning
    Haddrick, Malcolm
    Jones, Natalie H.
    Li, Shaobin
    Li, Xiuwei
    Liu, Yang
    Nguyen, Toan B.
    O'Connell, Nichole
    Rivers, Emma
    Robbins, Daniel W.
    Tomlinson, Ronald
    Yao, Tieguang
    Zhu, Xiahui
    Ferguson, Andrew D.
    Lamb, Michelle L.
    Manchester, John I.
    Guichard, Sylvie
    CHEMMEDCHEM, 2018, 13 (03) : 231 - 235
  • [46] Discovery and preclinical profile of a highly potent and muscle selective androgen receptor modulator (SARM)
    Hamann, LG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U6 - U6
  • [47] Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1
    Cherney, Emily C.
    Zhang, Liping
    Nara, Susheel
    Zhu, Xiao
    Gullo-Brown, Johnni
    Maley, Derrick
    Lin, Tai-An
    Hunt, John T.
    Huang, Christine
    Yang, Zheng
    Darienzo, Celia
    Discenza, Lorell
    Ranasinghe, Asoka
    Grubb, Mary
    Ziemba, Theresa
    Traeger, Sarah C.
    Li, Xin
    Johnston, Kathy
    Kopcho, Lisa
    Fereshteh, Mark
    Foster, Kimberly
    Stefanski, Kevin
    Fargnoli, Joseph
    Swanson, Jesse
    Brown, Jennifer
    Delpy, Diane
    Seitz, Steven P.
    Borzilleri, Robert
    Vite, Gregory
    Balog, Aaron
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 288 - 294
  • [48] Discovery of a highly potent and in vivo efficacious Bcl-xL selective inhibitor
    Tao, Zhi-Fu
    Wang, Le
    Nimmer, Paul M.
    Boghaert, Erwin R.
    Chen, Jun
    Hasvold, Lisa A.
    Jin, Sha
    Kovar, Peter J.
    Mitten, Michael J.
    Oleksijew, Anatol
    Park, Chang H.
    Petros, Andrew M.
    Phillips, Darren C.
    Smith, Morey
    Tahir, Stephen X.
    Tse, Chris
    Wang, Xilu
    Xiao, Yu
    Zhang, Haichao
    Deshayes, Kurt
    Fairbrother, Wayne J.
    Flygare, John A.
    Hymowitz, Sarah G.
    Koehler, Michael
    Ndubaku, Chudi
    Rawson, Tom
    Zobel, Kerry
    Colman, Peter M.
    Czabotar, Peter E.
    Huang, David C. S.
    Lessene, Guillaume
    Sleebs, Brad E.
    Watson, Keith G.
    Leverson, Joel D.
    Elmore, Steven W.
    Souers, Andrew J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [49] Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
    Shimizu, Kazuo
    Fujikura, Hideki
    Fushimi, Nobuhiko
    Nishimura, Toshihiro
    Tatani, Kazuya
    Katsuno, Kenji
    Fujimori, Yoshikazu
    Watanabe, Shinjiro
    Hiratochi, Masahiro
    Nakabayashi, Takeshi
    Kamada, Noboru
    Arakawa, Koichi
    Hikawa, Hidemasa
    Azumaya, Isao
    Isaji, Masayuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 34
  • [50] Discovery of BMS-962212 a highly potent, selective inhibitor of coagulation FXIa
    Pinto, Donald
    Orwat, Michael
    Smith, Leon, II
    Shrivastava, Shefali
    Quan, Mimi
    Lam, Patrick
    Rossi, Karen
    Apedo, Atsu
    Bozarth, Jeffrey
    Wu, Yiming
    Zheng, Joanna
    Xin, Baomin
    Toussaint, Nathalie
    Stetsko, Paul
    Gudmundsson, Olafur
    Crain, Earl
    Wong, Pancras
    Lou, Zhen
    Harper, Timothy
    Chacko, Silvi
    Myers, Joseph
    Sheriff, Steven
    Zhang, Huiping
    Hou, Xiaoping
    Mathur, Arvind
    Seiffert, Dietmar
    Luettgen, Joseph
    Wexler, Ruth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
12345